Emilio Usala

Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia

Francesco Zaja, Michele Baccarani, Patrizio Mazza et al. · Blood · 2010 · 259 citations

Life Sciences, Immunology, Pharmacotherapy +7

SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub

Rocco Piazza, Vera Magistroni, Sara Redaelli et al. · Nature Communications · 2018 · 157 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

Safety and efficacy of everolimus, a mTOR inhibitor, as single agent in a phase 1/2 study in patients with myelofibrosis

Paola Guglielmelli, Giovanni Barosi, Alessandro Rambaldi et al. · Blood · 2011 · 149 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Recurrent ETNK1 mutations in atypical chronic myeloid leukemia

Carlo Gambacorti‐Passerini, Carla Donadoni, Andrea Parmiani et al. · Blood · 2014 · 131 citations · Full text

Medicine, Genetics, Oncology +12

Residual Peripheral Blood CD26+ Leukemic Stem Cells in Chronic Myeloid Leukemia Patients During TKI Therapy and During Treatment-Free Remission

Monica Bocchia, Anna Sicuranza, Elisabetta Abruzzese et al. · Frontiers in Oncology · 2018 · 105 citations · Full text

Medicine, Hematology, Oncology +17